• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » BD appoints Rima Alameddine as Peripheral Intervention worldwide president

BD appoints Rima Alameddine as Peripheral Intervention worldwide president

May 17, 2024 By Danielle Kirsh

Rima Alameddine BD Peripheral Intervention president headshot.
Rima Alameddine, BD Peripheral Intervention worldwide president [Image courtesy of BD]
BD (NYSE: BDX) recently announced it appointed Rima Alameddine as the worldwide president of the BD Peripheral Intervention business unit.

The appointment took effect on May 13. Alameddine will be responsible for driving the global strategic, operational, quality and commercial excellence of the Peripheral Intervention business unit, according to BD. She will report to Executive VP and President of BD Interventional Rick Byrd.

“With more than 25 years of healthcare industry experience, Rima is a passionate leader with a track record of strong execution,” Byrd said in a news release. “The combination of Rima’s leadership and a vibrant pipeline of innovations put BD Peripheral Intervention in a strong position to accelerate growth for the business and serve patients across a variety of peripheral vascular and oncology applications.”

Alameddine has been with the company since 2015. She was most recently the worldwide president of BD Urology and Critical Care since October 2021. Prior to that role, Alameddine joined BD as the VP and general manager for C.R. Bard in Latin America and was appointed VP and general manager for the Oncology platform within BD Peripheral Intervention.

Before joining BD, Alameddine held numerous leadership roles at GE HealthCare over an 11-year span, including chief marketing officer for Latin America.

Other recent personnel moves at BD

Alameddine’s appointment follows other executive personnel moves at the company in recent months.

In February, Dave Hickey, EVP and president of Life Science, announced his intent to retire. Hickey plans for his retirement to go into effect on July 1, 2024. He originally joined BD in 2014, serving as president of Diagnostic Systems. He became president of Integrated Diagnostic Solutions in 2019 and began leading the Life Sciences segment in January 2021.

The company also appointed Rian Seger president of BD Surgery in April. Before becoming president of BD Surgery, Seger was VP and general manager of BD’s Medication Delivery Solutions business unit within the BD Medical segment. Seger reports to Byrd and is responsible for driving the global strategic, operational, and commercial performance of BD Surgery.

Filed Under: Business/Financial News, Featured Tagged With: BD, Personnel Moves, Women in Medtech

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy